Illumina stock rallies 5.29% and outperforms competitors
Updated
Updated · MarketWatch · Apr 30
Illumina stock rallies 5.29% and outperforms competitors
9 articles · Updated · MarketWatch · Apr 30
Shares closed at $126.74 on Thursday, with trading volume of 2.4 million topping the 50-day average of 1.6 million.
The gain ended a two-day losing streak during a broader market advance, as the S&P 500 rose 1.02% and the Dow Jones Industrial Average gained 1.62%.
Illumina still finished 18.51% below its 52-week high of $155.53 reached on 22 January, while it beat Labcorp, Charles River Laboratories and Quest Diagnostics on the day.
After a strong quarter, can Illumina overcome its flat growth, insider selling, and mixed analyst ratings?
Can Illumina's short-read tech survive the rise of cheaper, more accurate long-read sequencing rivals?
As Illumina pushes AI in genomics, can it navigate the growing global maze of data privacy laws?